Novo Nordisk

For almost 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, like our insulin pens. 

Our treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases. 

From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients throughout the world.

Our focus is on the serious chronic diseases that affect hundreds of millions of people and are among the most urgent global health challenges. By combining our innovation and commercial excellence, we draw upon insights from patients and partners to transform bold ideas into life-saving and preventive medicines.

We make long-term investments in novel treatments and technologies, including curative stem cell-based therapies, to continually advance the development of medical devices and digital health solutions.